Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 02, 2023

BUY
$1.16 - $6.41 $75,516 - $417,291
65,100 New
65,100 $75,000
Q4 2022

Jan 26, 2023

BUY
$4.78 - $15.01 $61,662 - $193,629
12,900 Added 24.71%
65,100 $343,000
Q3 2022

Oct 27, 2022

BUY
$10.22 - $23.7 $352,590 - $817,650
34,500 Added 194.92%
52,200 $601,000
Q2 2022

Jul 25, 2022

BUY
$4.35 - $15.85 $57,854 - $210,805
13,300 Added 302.27%
17,700 $200,000
Q1 2022

Apr 21, 2022

BUY
$4.55 - $6.41 $20,020 - $28,204
4,400 New
4,400 $21,000
Q4 2021

Jan 24, 2022

SELL
$5.89 - $9.73 $38,874 - $64,218
-6,600 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$6.78 - $9.89 $205,434 - $299,667
-30,300 Reduced 82.11%
6,600 $56,000
Q2 2021

Jul 26, 2021

BUY
$7.24 - $11.2 $25,340 - $39,200
3,500 Added 10.48%
36,900 $297,000
Q1 2021

Apr 23, 2021

BUY
$8.05 - $20.78 $268,870 - $694,052
33,400 New
33,400 $359,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $41.7M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.